Lundbeck, Teva settle Cipralex patent fight; Watson wins FDA nod for Pulmicort copy;

@FiercePharma: Watson got FDA nod for its Pulmicort knockoff. Patent fight with AstraZeneca pending, so no launch yet. Report | Follow @FiercePharma

> Lundbeck said it had settled with Teva Pharmaceutical Industries ($TEVA) in a patent fight over its antidepressant Cipralex. Report

> Watson Pharmaceuticals ($WPI) won FDA approval for its version of the $1.1 billion AstraZeneca asthma drug Pulmicort, but a patent fight between the two companies is still pending. Report

> Optimer Pharmaceuticals ($OPTR) got a boost from Centers for Medicare & Medicaid Services, which bumped up reimbursement for hospital use of its C. difficile treatment Dificid. Report

> Alliance Pharma snapped up three antimalarial brands from AstraZeneca ($AZN) for £4.2 million ($6.5 million), plus up to £1 million ($1.5 million), depending upon future sales. Report

> The U.K. government plans to change National Health Service rules to allow patient data to be used by the pharma industry in research. Report

Medical Device News

@FierceMedDev: The $3.8B deal is done. Hologic wrapped up its bid to acquire Gen-Probe. Release | Follow @FierceMedDev

 @MarkHFierce: Regulators in Singapore lowered import fees for blood pressure monitors and hearing aids. More | Follow @MarkHFierce

 @DamianFierce: Covidien has opened up its $45M R&D shop in Shanghai. News | Follow @DamianFierce

> CareFusion hit with Class I recall of infusion pump component. News

> Becton, Dickinson trims expectations after Q3 loss. More

Biotech News

 @FierceBiotech: RIP: After long illness, Genta finally opts to liquidate. News | Follow @FierceBiotech

 @JohnCFierce: Bristol's bad, awful, not very good day. Pensions exec charged with insider trading, via Bloomberg. And it's still early. More | Follow @JohnCFierce

 @RyanMFierce: A Google search for scientific experts? AstraZeneca adopts search engine for scientists from David Steinberg's Knode. Article | Follow @RyanMFierce

> R&D shift sees new jobs in China as Western ops are restructured. Article

> Report: Bristol exec nabbed on insider trading charge. Item

> Halozyme blitzed as FDA rejects Baxter drug, halts combo trial. Story

> Analyst reads last rites after heart failure scuttles Bristol hep C study. News

Vaccines News

> Old whooping cough vax more effective than new. News

> AstraZeneca wins Fluenz contract in U.K. Article

> Survey: U.S. females fail to finish Merck and GSK HPV shots. More

> NIH awards $5M for heroin addiction, AIDS vaccine. News

> Alnylam gets $3.2M milestone from GSK for vax tech. Story

Pharma Manufacturing News 

> Hospira CEO Ball says it's getting 'gators' under control. Report

> Rexam eyes factory growth, despite lagging healthcare sales. More

> CMC nabs Xoma's Bay Area plant. Article

And Finally ... Would patients risk side effects in the hopes of preventing a heart attack? Depends which side effects. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.